Skip to main content
Tech.euFundingExplorerBeta

Integra Therapeutics

Next-generation gene-editing tools to boost the efficiency and safety of advanced therapies.

Integra Therapeutics has raised €27M across 4 funding rounds from 9 investors, most recently a Seed round in Sep 2025. Based in Barcelona, Spain; active in Healthtech. Data as of 28 Oct 2026.

Barcelona, Spainintegra-tx.com ↗
Healthtech
← All companies
Total raised
€27M
€27,200,000
Funding rounds
4
Investors
9
distinct backers
Active since
2021-12
latest 2025-09

Funding by year

EUR raised per year
Integra Therapeutics — funding by year — interactive chart.
Data table
Integra Therapeutics — funding by year
2021€4.5M
2022€1.5M
2024€11M
2025€11M

Signals

High confidence
Raise-next likelihood62
base rate 44% for Seed
  • ▲ In typical raise window
  • ▼ Low backer re-investment
Exit likelihood21
base rate 11% (2+ rounds)
  • ▲ 4 rounds raised
  • ▲ 5y since founding (typical exit age)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds
DateStageAmountInvestors
2025-09-09Seed€11MAdBio partners,CDTI Innvierte,Columbus Venture Partners,EIC Fund,Invivo Capital Partners,Takeda VenturesView deal →
2024-07-17Other€11MEuropean Innovation Council (EIC) Accelerator ProgrammeView deal →
2022-03-29Other€1.5MColumbus Venture PartnersView deal →
2021-12-02Other€4.5MAdvent France Biotechnology,Invivo Capita I,Takeda VenturesView deal →

Investors

9
AdBio partnersAdvent France BiotechnologyCDTI InnvierteColumbus Venture PartnersEIC FundEuropean Innovation Council (EIC) Accelerator ProgrammeInvivo Capita IInvivo Capital PartnersTakeda Ventures

Related news

Similar companies

same sector or country

Global coverage: FundingData